Cargando…
Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: The case of hydroxychloroquine in COVID-19
Autores principales: | Sala, Luca, Leonov, Vladislav, Mura, Manuela, Moretti, Alessandra, Crotti, Lia, Gnecchi, Massimiliano, Schwartz, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560754/ http://dx.doi.org/10.1016/j.vph.2022.107075 |
Ejemplares similares
-
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19
por: Sala, Luca, et al.
Publicado: (2022) -
A mathematical model of hiPSC cardiomyocytes electromechanics
por: Forouzandehmehr, Mohamadamin, et al.
Publicado: (2021) -
Practical adoption of state-of-the-art hiPSC-cardiomyocyte differentiation techniques
por: Rupert, Cassady E., et al.
Publicado: (2020) -
An in silico hiPSC-Derived Cardiomyocyte Model Built With Genetic Algorithm
por: Akwaboah, Akwasi D., et al.
Publicado: (2021) -
Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes
por: Ulmer, Bärbel M., et al.
Publicado: (2018)